Clinical Trials Directory

Trials / Completed

CompletedNCT03104127

Effect of Using a Lower Limb Robotic Device for Patients With Chronic Stroke

Effect of a Community-based, Bionic Leg Rehabilitation Program on Biomechanical, Cardiovascular and Performance Outcomes in Patients With Chronic Stroke

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
University of Winchester · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This study will investigate if a lower limb robotic device can be used in a community setting to increase the amount of physical activity that individuals undertake following stroke and consequently improve biomechanical, physiological and health outcomes, in patients with stroke.

Detailed description

Recent advances in technology have helped to develop robotic devices to aid gait training in order to develop more normal movement patterns, strengthen the quadriceps and improve quality of gait. Lower limb robotic devices have been shown to increase functional mobility, walking speed, step length, balance and endurance within a clinical setting. The purpose of this study is to see if a lower limb robotic device leg can be used in a community setting to improve biomechanical (gait, balance, lower-limb strength), physiological (vascular health) and performance outcomes (aerobic fitness, strength) in patients with chronic stroke

Conditions

Interventions

TypeNameDescription
DEVICEAlter G Bionic LegParticipants are randomized to a 10 week, community-based bionic leg programme. Participants must use the leg for a minimum of 1 hour per day and continue to have active physical therapy sessions.
OTHERNormal therapy (physiotherapy)Participants are randomized to a normal therapy (physiotherapy) only program. Participants are also advised to undertake 1 hour a day of physical activity and have active physical therapy (physiotherapy) sessions.

Timeline

Start date
2017-04-24
Primary completion
2019-07-01
Completion
2019-07-01
First posted
2017-04-07
Last updated
2020-01-18

Locations

1 site across 1 country: United Kingdom

Regulatory

Source: ClinicalTrials.gov record NCT03104127. Inclusion in this directory is not an endorsement.